Category Archives: Patent Eligible Subject Matter

C. R. Bard v. Angiodynamics – It’s a Labelled Injection Port, not a Label

The recent decision in C. R. Bard, Inc. v. Angiodynamics Inc., Appeal nos. 2019-1756 and 2019-1934 (Fed. Cir., November 10, 2020) is an example of a bad doctrine, patent eligibility, gone rogue. The panel’s ultimate decision that the claimed invention … Continue reading

Posted in Patent Eligible Subject Matter | Tagged | Leave a comment

XY, LLC v. Trans Ova Genetics, Inc. – Building on Illumina v. Ariosa

In XY v. Trans Ova Genetics, Inc., Appeal No. 2019-1789 (Fed. Cir. July 31, 2020), a panel of Wallach, Plager and Stoll reversed the district court’s finding that claims to an improved method of cell sorting are patent ineligible under … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , | Leave a comment

AAM v. Neapco – Part IV – Petition for Rehearing En Banc Denied – “Bad Vibrations”

This post will briefly discuss the Fed. Cir.’s denial of rehearing en banc – which  left the modified panel opinion stand. The lengthy panel opinion has been the subject of my last three posts, and you should read them before … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , | Leave a comment

AAM v. Neapco Part II– Judge Moore’s Dissent – Nothing More = Nevermore?

My first post on this troubling decision is dated August 3rd. If you have not already, please read it before you read this one. It focuses on the two judge majority opinion, that found that a claim to a method … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , | Leave a comment